Wellman Center for Photomedicine

What Wellman Center for Photomedicine does

Wellman Center for Photomedicine is a non-profit academic research center located at Massachusetts General Hospital in Boston, Massachusetts, and operating as a thematic research center within Mass General Brigham with formal affiliation to Harvard Medical School. The center is structured around 14 specialized laboratories (Aguirre, Anderson, Bouma, Evans, Hasan, Lin, Nadkarni, Redmond, Tearney, Tsao, Vakoc, Wu, and Yun) conducting research that spans optics, photonics, engineering, chemistry, physics, advanced biological techniques, and computational approaches. Its stated mission is to develop and apply light-based diagnostic and therapeutic technologies to clinical problems.

The technology portfolio includes optical coherence tomography (OCT, co-invented by Dr. Seok-Hyun Yun), photodynamic therapy (PDT), blue light antimicrobial therapy, Brillouin microscopy, bio-lasers and biocompatible photonics, microneedle array delivery systems, and photobiomodulation. Application areas span cancer, cardiovascular disease, infectious disease (including sepsis and multi-drug resistant infections), wound healing, vision loss, pain management, dermatology, transplantation, trauma, sleep apnea, and precision surgery. The center holds over 50 U.S. patents and has 22 clinical innovations that have been licensed, commercialized, and are in worldwide use, with multiple FDA-approved products among them.

Wellman's revenue model is non-commercial in the traditional sense. Funding flows from federal and institutional research grants (primarily NIH), philanthropic donations, and technology licensing royalties. The center supports technology transfer to industry partners through licensing agreements and has recently introduced an internal investment fund for biotech commercialization led by Dr. Lynn Drake. Its "customers" are best understood as patient populations across multiple disease areas, military and wounded-warrior populations, industry licensees, and the broader academic-clinical ecosystem served through publications, conferences, and clinical collaborations.

Name

Wellman Center for Photomedicine

Legal name

Wellman Center for Photomedicine

Website

https://wellman.massgeneral.org

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

The Wellman Center for Photomedicine is a non-profit academic research center at Massachusetts General Hospital that develops light-based diagnostic and therapeutic technologies across cancer, cardiovascular disease, infectious disease, and dermatology, licensing discoveries to industry while operating 14 specialized laboratories under Mass General Brigham.

Ownership category

akta.pro rank

Product category

Photomedicine Research

NAICS

Diagnostic Imaging Centers (621512), Offices of Optometrists (62132)

SIC

Surgical & Medical Instruments & Apparatus (3841), Optical Instruments & Lenses (3827), Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)

akta.pro primary industry

Microscopy, Imaging & Flow Cytometry Instruments (HLAGAIAE)

akta.pro secondary industries

Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation) (HLAHADAB), Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology) (HLAFAKAB), Ocular Imaging & Diagnostic Testing Centers (HLAKAKAN), Vision & Ophthalmic Diagnostic Centers (Optometry/OCT/Retinal Imaging) (HLAFAKAI)

Keywords

• Photomedicine research
• Biomedical imaging technologies
• Photodynamic therapy
• Optical coherence tomography
• Light-based medical therapies

Headquarters

HQ city

Boston

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure

Revenue model

1. Research Funding: Federal and institutional research grants primarily from NIH and other funding agencies supporting academic research operations
2. Donations and Philanthropy: Gifts from donors supporting the discovery, understanding, and application of new diagnostic and therapeutic uses of light in biomedicine
3. Technology Commercialization: Licensing of discoveries to industry partners; Dr. Drake created an investment fund focused on biotech commercialization from academic discoveries; Wellman has 22 clinical innovations that have been commercialized and are in worldwide use

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

The Wellman Center for Photomedicine is an academic research center at Massachusetts General Hospital that develops and applies light-based and optical technologies to advance medical science. It operates 14 specialized laboratories conducting research across optics, photonics, engineering, chemistry, physics, and computational biology, with a track record of 22 commercialized clinical innovations. Core research spans in vivo imaging, optical coherence tomography, photodynamic therapy, blue light antimicrobial therapy, and Brillouin microscopy.

Product overview

The Wellman Center for Photomedicine is a research institution specializing in the development and application of light-based technologies for medical science and clinical solutions. Rather than a commercial product portfolio, the Center operates as a collaborative research environment with 13 specialized laboratories (Aguirre, Anderson, Bouma, Evans, Hasan, Lin, Nadkarni, Redmond, Tearney, Tsao, Vakoc, Wu, and Yun labs) conducting research across optics, photonics, engineering, chemistry, physics, and computational biology. Research focuses on key areas including in vivo imaging, cancer diagnosis and treatment, cardiovascular disease detection, infectious disease therapy using blue light antimicrobials, wound healing, and optical coherence tomography technologies.

Differentiator

Problem solved

Functional benefit

Products and services

• Wellman Center Research Portfolio

Quantifiable outcome

• 22 clinical innovations have been commercialized and are in worldwide use for the benefit of patients
• +2 more outcomes

Named customers2 records

Segments7 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

Four partnerships are on record, tiered core.

• Massachusetts General HospitalcoreStrategic or Co-development PartnerWellman Center is a thematic research center at MGH, specializing in development and application of new technologies to advance medical science. The center is a founding member of Mass General Brigham.
• Harvard Medical SchoolcoreStrategic or Co-development PartnerAffiliated with Harvard Medical School for academic research and training purposes. Many faculty hold positions at HMS.
• MIT (Massachusetts Institute of Technology)coreStrategic or Co-development PartnerDr. Yun is an affiliated faculty member at MIT (Health Sciences and Technology). Collaborative research in biomedical optics.
• Mass General BrighamcoreStrategic or Co-development PartnerWellman Center is an MGB thematic research center. MGB is a healthcare system encompassing multiple hospitals including MGH.

Scale indicators4 records

Recent moves3 records

Expansion highlights5 records

Emerging players

• Optovue (Visionix): OCT and ophthalmic imaging company now part of Visionix. Comparable as a focused OCT device vendor whose commercial products leverage the same Fourier-domain and clinical-OCT foundations that Wellman continues to research and extend.
• Lumedica: Low-cost OCT imaging developer spun out of biomedical optics research. Comparable as an emerging commercial entity translating research-grade OCT into clinical and point-of-care use, mirroring the Wellman-to-industry translation pathway.

Direct peers

• Heidelberg Engineering: Specialized OCT and ophthalmic imaging company. Highly comparable to Wellman because both advance OCT instrumentation for ophthalmology, with Heidelberg's commercial products building on the same foundational imaging modalities that Wellman's Bouma, Yun, and Tearney labs continue to extend.
• Hamamatsu Photonics: Photonics and photodetector manufacturer with growing life science and medical focus. Comparable because Wellman's optical and photodetector-based imaging platforms (OCT, Brillouin, in vivo microscopy) overlap with Hamamatsu's core optical-sensing and photonics technologies.
• Beckman Laser Institute & Medical Clinic: Biomedical photonics research and clinical translation center at UC Irvine. One of the closest institutional peers to Wellman: both operate as interdisciplinary photomedicine research hubs with translational, clinical, and technology transfer activities in light-based diagnostics and therapeutics.
• Thorlabs: Broad-line photonic and optical components supplier. Comparable because Wellman relies on similar photonic and optical instrumentation infrastructure (lasers, OCT engines, Brillouin components) and frequently commercializes or co-develops with adjacent vendors in the optics ecosystem.
• Leica Microsystems: Leading microscopy and optical imaging provider. Comparable because Wellman develops advanced microscopy, in vivo imaging, and fluorescence imaging technologies that overlap with Leica's core product categories in research and clinical microscopy.
• Carl Zeiss Meditec: Global leader in ophthalmic diagnostics, OCT, and surgical microscopy. Directly comparable because Wellman co-invented Fourier-domain OCT (a foundational Zeiss ophthalmic technology) and develops adjacent imaging and microscopy instrumentation used in similar clinical settings.
• NIDEK: Manufacturer of ophthalmic and optometric diagnostic equipment, including OCT. Comparable because Wellman develops ophthalmic imaging and vision-protective technologies (wet macular degeneration, glaucoma) that sit upstream of NIDEK's commercial diagnostic systems.
• Olympus: Major manufacturer of endoscopes, microscopy, and optical imaging systems. Comparable because Wellman's high-speed, high-resolution endoscopic and intravascular imaging research directly parallels Olympus's core endoscopy and minimally invasive imaging franchises.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/wellmancenter

Revenue estimate

Valuation estimate

Number of profiles

Profiles14 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Wellman Center for Photomedicine